Statin Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome
Condition:   Mi Q Wave Interventions:   Device: Turbox CRP kit;   Drug: rosuvastatin 20 mg,;   Drug: atorvastatin 40 mg Sponsor:   Rawalpindi Medical College Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials

Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome
Conditions: Mi Q Wave Interventions: Device: Turbox CRP kit; Drug: rosuvastatin 20 mg,; Drug: atorvastatin 40 mg Sponsors: Rawalpindi Medical College Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials

Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study
Condition:   Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis Interventions:   Drug: Alirocumab;   Drug: Atorvastatin Sponsor:   The First Affiliated Hospital with Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials

Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study
Conditions: Stroke; Intracranial Atherosclerotic Stenosis Interventions: Drug: Alirocumab; Drug: Atorvastatin Sponsors: The First Affiliated Hospital with Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials

The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy
Condition:   Diabetic Peripheral Neuropathy Interventions:   Drug: hypoglycemic Agents(metformin);   Drug: lipid-lowering drug(Statin) Sponsor:   First Affiliated Hospital of Wenzhou Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials